April 25, 2008
The UNC School of Pharmacy has named Rudy Juliano, PhD, an expert in drug targeting, as its new associate dean for research and graduate education.
Juliano fills the vacancy left by Dhiren Thakker, PhD, who stepped down to pursue other projects at the School. Before coming to the School, Juliano was the Cary C. Boshamer Distinguished Professor in the Department of Pharmacology at the UNC School of Medicine, where he served as department chair from 1987 to 2002.
In his new position, Juliano will oversee the School’s research and graduate education programs. One key component of his responsibilities will be helping faculty land more large, multi-investigator grants.
“We couldn’t have found a better fit for this position than Dr. Juliano,” says Bob Blouin, dean of the School. “He is an outstanding scientist, and he also brings a vast amount of knowledge and experience in the administration of research and graduate education, which will be important assets. In particular, Dr. Juliano’s experience with training, center, and program project grants will add tremendous value as our research and graduate programs continue to advance.”
Juliano is no stranger to the School. He has been a longtime instructor in pharmacology courses offered to pharmacy students, and he has collaborated with many faculty members at the School on research projects.
“I was very impressed with the developments at the School of Pharmacy in terms of the evolution of the research efforts, especially in the last few years,” says Juliano, who will be a professor in the Division of Molecular Pharmaceutics and retain a joint appointment in the Department of Pharmacology. “When Dhiren decided to step down, it just seemed like an interesting opportunity to get involved in research administration again in a very dynamic atmosphere.”
In addition to his administrative duties, Juliano will also continue his own research, which currently focuses on drug delivery and macromolecular therapies for cancer. He is also the principal investigator for the Carolina Center of Cancer Nanotechnology Excellence. The center, funded by the National Cancer Institute, offers a venue through which scientists from various disciplines work together to develop novel nanotechnology approaches for cancer diagnosis and treatment.
Before coming to UNC in 1987, Juliano spent nine years at the University of Texas Medical School, where he rose to full professor. He earned his BS in physics at Cornell University and his PhD in biophysics at the University of Rochester. Juliano completed a postdoctoral fellowship in experimental pathology at Roswell Park Memorial Hospital in Buffalo, New York. He began his career as an investigator at the Research Institute at The Hospital for Sick Children in Toronto while serving as an assistant professor at the University of Toronto.
Juliano has served on numerous NIH study sections, as well as the editorial boards of Cancer Research, Pharmaceutical Research, Biochimica et Biophysica Acta, Journal of Drug Targeting, Oligonucleotides, Molecular Pharmacology, Advanced Drug Delivery Reviews, and the Journal of Cell Biology. He also was named a Fogarty Fellow at the Wellcome-CRC Institute at Cambridge, England, in 1993.
Latest News
Dean Angela Kashuba receives Carolina Alumni Faculty Service Award
RASP poster presentations capture student research
